Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell × ixazomib × Clear all

NCT02158975 2017-11-13

Open-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell Lymphomas

Phase 2 Completed

13 enrolled 10 charts

Lymphoma, T-Cell